CLINICAL_TRIALS
trial_result
· 2014-05-20
Clinical Trial Update: Safety Study of Replagal® Therapy in Children With Fabry Disease [Phase 2]
Summary
Phase 2 safety study of Replagal therapy in children with Fabry disease has completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Fabry Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-05-20